End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015
Summary
GlobalData's clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015 provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7) , phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials) . Global Data Clinical Trial Reports are generated using Global Datas proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7) , Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) 26
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials 34
Prominent Drugs 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Amgen Inc. 36
Clinical Trial Overview of Amgen Inc. 36
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
F. Hoffmann-La Roche Ltd. 40
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 40
AstraZeneca Plc 41
Clinical Trial Overview of AstraZeneca Plc 41
Shire Plc 42
Clinical Trial Overview of Shire Plc 42
Sanofi 43
Clinical Trial Overview of Sanofi 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
DaVita HealthCare Partners Inc. 46
Clinical Trial Overview of DaVita HealthCare Partners Inc. 46
AbbVie Inc. 47
Clinical Trial Overview of AbbVie Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
Isfahan University of Medical Sciences 48
Clinical Trial Overview of Isfahan University of Medical Sciences 48
Shiraz University of Medical Sciences 49
Clinical Trial Overview of Shiraz University of Medical Sciences 49
The National Institute of Allergy and Infectious Diseases 50
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 50
Vanderbilt University 51
Clinical Trial Overview of Vanderbilt University 51
The National Institute of Diabetes and Digestive and Kidney Diseases 52
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 52
University of Alberta 53
Clinical Trial Overview of University of Alberta 53
Ahvaz Jundishapur University of Medical Sciences 54
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 54
Centre Hospitalier Universitaire Vaudois 55
Clinical Trial Overview of Centre Hospitalier Universitaire Vaudois 55
Columbia University 56
Clinical Trial Overview of Columbia University 56
Creighton University 57
Clinical Trial Overview of Creighton University 57
Five Key Clinical Profiles 58
Appendix 100
Abbreviations 100
Definitions 100
Research Methodology 101
Secondary Research 101
About GlobalData 102
Contact Us 102
Disclaimer 102
Source 103
List Of Tables
List of Tables
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region, 2015* 8
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 11
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 12
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries, 2015* 13
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 14
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 15
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 16
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 19
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase, 2015* 22
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Suspended Clinical Trials, 2015* 26
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Terminated Clinical Trials, 2015* 29
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 31
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 32
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 33
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 36
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 38
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 40
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 41
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 42
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 43
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 44
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 45
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by DaVita HealthCare Partners Inc., 2015* 46
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 47
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 48
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 49
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 50
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 51
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 52
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2015* 53
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2015* 54
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire Vaudois, 2015* 55
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 56
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2015* 57
List Of Figures
List of Figures
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region (%), 2015* 8
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 11
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 12
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 13
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 14
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 15
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 16
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 19
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 31
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 32
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 33
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35
GlobalData Methodology 101
